Who
Kenneth Wolf
President, COO, & Sec.
Company insider
Files Form 4 as: President, COO, & Sec., Natural Alternatives International; CFO and Treasurer, Phoenix Footwear Group.
In numbers
- Trades disclosed
- 61
- Buys
- 3
- Sells
- 2
- Bought
- $85K
- Sold
- $459K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 10 Feb 2006
- Last trade
- 6 Mar 2026
- Last filed
- 10 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $14K5,151 at $2.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $14K5,151 at $2.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 7 Mar 2025filed 11 Mar 2025 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $29K7,559 at $3.84 | filing |
| 8 Mar 2024filed 11 Mar 2024 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —14,500 at $0.00 | filing |
| 7 Mar 2024filed 11 Mar 2024 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $39K6,533 at $5.95 | filing |
| 7 Mar 2023filed 9 Mar 2023 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 7 Mar 2023filed 9 Mar 2023 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $27K2,992 at $8.86 | filing |
| 7 Mar 2022filed 8 Mar 2022 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $56K5,107 at $11.00 | filing |
| 4 Mar 2022filed 8 Mar 2022 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 15 Mar 2021filed 18 Mar 2021 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 8 Mar 2021filed 10 Mar 2021 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $110K7,326 at $15.05 | filing |
| 26 Feb 2021filed 2 Mar 2021 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Sold | $359K22,255 at $16.13 | filing |
| 16 Nov 2020filed 18 Nov 2020 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Sold | $100K9,630 at $10.35 | filing |
| 1 Oct 2020filed 5 Oct 2020 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $39K5,265 at $7.40 | filing |
| 17 Apr 2020filed 27 Apr 2020 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code J | —20,000 at $0.00 | filing |
| 1 Apr 2020filed 2 Apr 2020 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 10 Mar 2020filed 12 Mar 2020 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $76K10,983 at $6.91 | filing |
| 1 Oct 2019filed 4 Oct 2019 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $45K5,265 at $8.50 | filing |
News
Kenneth Wolfeyourdailyglobe.com · 9 Sep 2026
1 headline in the last 90 days name Kenneth Wolf; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.